For journalists, producers, and conference programmers.
BioThera's founder is a named contributor to MISEV2023, the international consensus standard for extracellular vesicle research. He is available as an expert source on EV science, the exosome skincare market, EV biomanufacturing, and Canadian biotech. Media kit and direct contact below.
Where BioThera has been mentioned
Coverage list: currently empty
This page is published openly without manufactured placeholders. Real coverage will be listed here as it appears. If you are a journalist, podcaster, or producer building a story in this space, the founder is available; see expertise areas and contact below.
Topics the founder can speak to
Frédéric St-Denis-Bissonnette, PhD, Founder & CEO. Named contributor to MISEV2023. Fulbright Canada Entrepreneurship Award (MIT). First-author publications in Journal of Extracellular Vesicles, Journal of Extracellular Biology, Langmuir, JoVE, and Nanomaterials.
Topic 01
Extracellular vesicles and the MISEV2023 consensus
Founder Frédéric St-Denis-Bissonnette is a named contributor to MISEV2023, the international consensus guidelines published by the International Society for Extracellular Vesicles. He can speak to what the field's quality standards actually require and where commercial EV products often fall short.
Topic 02
Plant-derived versus mammalian extracellular vesicles
Comparative biology, safety, scalability, and regulatory pathway for plant-derived versus mammalian-derived EVs in the context of dermocosmetic and EV-based skincare applications. Where the evidence is mature, where it is preliminary, and where it is being overstated in the EV skincare category.
Topic 03
The exosome skincare market and how to evaluate a product
Why the word "exosome" is used incorrectly on most cosmetic labels, what a defensible Certificate of Analysis looks like, and the clinician-facing five-criteria framework BioThera publishes for evaluating EV products.
Topic 04
EV biomanufacturing at scale
The infrastructure gap that has prevented EV products from leaving the bench. Hollow-fibre bioreactor formats, isolation workflows that preserve the biomolecular corona, MISEV2023-aligned batch release.
Topic 05
Canadian biotech, Ottawa ecosystem, Fulbright research-to-startup pathway
St-Denis-Bissonnette holds a Fulbright Canada Entrepreneurship Award (hosted at MIT) and is a graduate of Ottawa's research-to-startup programs. Available for stories on Canadian biotech, federal research commercialization, and the founder-as-scientist model.
Logos, headshots and brand assets
All assets on this page may be used in editorial coverage of BioThera Solutions without prior approval. Higher-resolution versions and additional assets are available on request.
Pitch an interview, request an interview, or fact-check a quote
The fastest route is the contact form with press as the intent. Responses go out within one business day.